{"address1": "5858 Horton Street", "address2": "Suite 455", "city": "Emeryville", "state": "CA", "zip": "94608", "country": "United States", "phone": "510 505 2680", "website": "https://www.4dmoleculartherapeutics.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "4D Molecular Therapeutics, Inc., a late-stage biotechnology company, engages in the development of adeno-associated virus vectors from its proprietary synthetic vector discovery platform, Therapeutic Vector Evolution in the Netherland and the United States. The company's lead product candidate, 4D-150 for the treatment of retinal vascular diseases by providing multi-year sustained production of anti-VEGF from the retina with a single, safe, and intravitreal injection; and 4D-710 for the treatment of cystic fibrosis through early-stage studies. It also develops 4D-175 for geographic atrophy in preclinical with open IND; 4D-725 for alpha-1 anti-trypsin deficiency lung disease in preclinical; and 4D-310 for Fabry disease, which is in Phase 1 clinical trials. The company has collaboration and licensing agreements with Astellas Gene Therapies, Inc.; Arbor Biotechnologies, Inc.; uniQure biopharma B.V; and Cystic Fibrosis Foundation. 4D Molecular Therapeutics, Inc. was founded in 2013 and is headquartered in Emeryville, California.", "fullTimeEmployees": 227, "companyOfficers": [{"maxAge": 1, "name": "Dr. John F. Milligan Ph.D.", "age": 63, "title": "Executive Chairman", "yearBorn": 1961, "fiscalYear": 2023, "totalPay": 150000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. David H. Kirn M.D.", "age": 61, "title": "Co-Founder, CEO & Director", "yearBorn": 1963, "fiscalYear": 2023, "totalPay": 1008093, "exercisedValue": 0, "unexercisedValue": 308925}, {"maxAge": 1, "name": "Dr. Fariborz  Kamal Ph.D.", "age": 61, "title": "President & COO", "yearBorn": 1963, "fiscalYear": 2023, "totalPay": 786201, "exercisedValue": 0, "unexercisedValue": 3869287}, {"maxAge": 1, "name": "Dr. Noriyuki  Kasahara M.D., Ph.D.", "age": 61, "title": "Chief Scientific Officer", "yearBorn": 1963, "fiscalYear": 2023, "totalPay": 201288, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Robert Y. Kim M.B.A., M.D.", "age": 63, "title": "Chief Medical Officer", "yearBorn": 1961, "fiscalYear": 2023, "totalPay": 704843, "exercisedValue": 0, "unexercisedValue": 567555}, {"maxAge": 1, "name": "Ms. Theresa  Janke", "age": 49, "title": "Co-Founder & Chief of Staff", "yearBorn": 1975, "fiscalYear": 2023, "totalPay": 652315, "exercisedValue": 0, "unexercisedValue": 703125}, {"maxAge": 1, "name": "Mr. Uneek  Mehra", "age": 51, "title": "Chief Financial & Business Officer", "yearBorn": 1973, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Scott P. Bizily J.D., Ph.D.", "age": 52, "title": "Chief Legal Officer & Corporate Secretary", "yearBorn": 1972, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. An  Song Ph.D.", "title": "Chief Development Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Alan H. Cohen FAAAAI, FAAP, FACAAI, FCCP, M.D.", "age": 63, "title": "Senior VP & Therapeutic Area Head of Pulmonology", "yearBorn": 1961, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 5, "boardRisk": 6, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 8, "governanceEpochDate": 1743465600, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 3.23, "open": 3.21, "dayLow": 2.87, "dayHigh": 3.23, "regularMarketPreviousClose": 3.23, "regularMarketOpen": 3.21, "regularMarketDayLow": 2.87, "regularMarketDayHigh": 3.23, "payoutRatio": 0.0, "beta": 2.822, "forwardPE": -0.9088146, "volume": 1546216, "regularMarketVolume": 1546216, "averageVolume": 816861, "averageVolume10days": 815580, "averageDailyVolume10Day": 815580, "bid": 2.93, "ask": 3.02, "bidSize": 1, "askSize": 1, "marketCap": 138444176, "fiftyTwoWeekLow": 2.87, "fiftyTwoWeekHigh": 29.265, "priceToSalesTrailing12Months": 3741.7344, "fiftyDayAverage": 4.5177, "twoHundredDayAverage": 10.491625, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -261826800, "profitMargins": 0.0, "floatShares": 34309158, "sharesOutstanding": 46302400, "sharesShort": 5028368, "sharesShortPriorMonth": 6167568, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.1086, "heldPercentInsiders": 0.03885, "heldPercentInstitutions": 1.03164, "shortRatio": 7.4, "shortPercentOfFloat": 0.113000005, "impliedSharesOutstanding": 46302400, "bookValue": 11.15, "priceToBook": 0.26816145, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -160868000, "trailingEps": -2.98, "forwardEps": -3.29, "enterpriseToRevenue": -7076.4, "enterpriseToEbitda": 1.429, "52WeekChange": -0.89290833, "SandP52WeekChange": 0.08089435, "quoteType": "EQUITY", "currentPrice": 2.99, "targetHighPrice": 65.0, "targetLowPrice": 6.0, "targetMeanPrice": 33.81818, "targetMedianPrice": 36.0, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 11, "totalCash": 424876992, "totalCashPerShare": 9.176, "ebitda": -183188000, "totalDebt": 24606000, "quickRatio": 14.576, "currentRatio": 14.921, "totalRevenue": 37000, "debtToEquity": 4.819, "revenuePerShare": 0.001, "returnOnAssets": -0.26081, "returnOnEquity": -0.39311, "grossProfits": -141262000, "freeCashflow": -82288624, "operatingCashflow": -134584992, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -56117.0, "financialCurrency": "USD", "symbol": "FDMT", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1607697000000, "marketState": "PRE", "regularMarketChangePercent": -7.4303412, "regularMarketPrice": 2.99, "shortName": "4D Molecular Therapeutics, Inc.", "longName": "4D Molecular Therapeutics, Inc.", "regularMarketChange": -0.24000001, "regularMarketDayRange": "2.87 - 3.23", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 816861, "fiftyTwoWeekLowChange": 0.120000124, "fiftyTwoWeekLowChangePercent": 0.04181189, "fiftyTwoWeekRange": "2.87 - 29.265", "fiftyTwoWeekHighChange": -26.275, "fiftyTwoWeekHighChangePercent": -0.8978302, "fiftyTwoWeekChangePercent": -89.29083, "earningsTimestamp": 1740776700, "earningsTimestampStart": 1746615540, "earningsTimestampEnd": 1747051200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -2.98, "epsForward": -3.29, "epsCurrentYear": -3.5693, "priceEpsCurrentYear": -0.8376993, "fiftyDayAverageChange": -1.5277002, "fiftyDayAverageChangePercent": -0.33815882, "twoHundredDayAverageChange": -7.501625, "twoHundredDayAverageChangePercent": -0.7150108, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2020-12-11", "averageAnalystRating": "2.0 - Buy", "corporateActions": [], "regularMarketTime": 1743537602, "exchange": "NMS", "messageBoardId": "finmb_272879653", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "displayName": "4D Molecular Therapeutics", "trailingPegRatio": null}